SEC Form 4 · accession 0001179110-15-004507
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank D Czworka Jr.
Officer — Vice President
Period of report
Mar 6, 2015
Accepted (ET)
Mar 9, 2015 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $18.40 | Mar 6, 2015 | A | 5,434 | A | Mar 6, 2016 | Mar 6, 2025 | Common Stock | 5,434 | 84,184 | D |
| Non-Qualified Stock Option (right to buy)F1 | $18.40 | Mar 6, 2015 | A | 19,566 | A | Mar 6, 2016 | Mar 6, 2025 | Common Stock | 19,566 | 103,750 | D |
Explanation of responses
- F1Options to purchase 25,000 shares of the common stock of the Registrant shall become exerciseable with respect to the underlying shares as to 25% on each March 6, 2016, 2017, 2018 and 2019, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.